Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

8.70USD
20 Jul 2018
Change (% chg)

$0.14 (+1.64%)
Prev Close
$8.56
Open
$8.62
Day's High
$8.71
Day's Low
$8.48
Volume
3,310
Avg. Vol
5,146
52-wk High
$15.75
52-wk Low
$5.48

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $92.41
Shares Outstanding(Mil.): 10.80
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 29.12 33.34
EPS (TTM): -1.93 -- --
ROI: -49.99 13.60 13.18
ROE: -61.02 15.30 15.09

Earnings vs. Estimates